Pharmaceutical Industry

Page 96 of 100

Stefano Pessina, Executive Deputy Chairm
Retail

Is Walgreens about to go shopping again?

By Reuters and Fortune Editors
March 12, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

Endo International makes competing bid for Salix Pharmaceuticals

By
March 11, 2015
Biotech pros’ top 8 stock picks
Tech

Biotech pros’ top 8 stock picks

By
March 9, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features

FDA approves the first biosimilar for the U.S. market

By
March 6, 2015
IL: Corporations In Illinois
Features

AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation’?

By
March 5, 2015
China stock market
Features

China cuts growth and a big pharma deal — 5 things to know today

By
March 5, 2015
IL: Corporations In Illinois
Finance

AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal

By
March 5, 2015
Inside of a Gilead Sciences Lab
Tech

Is the future of pharma about making good drugs great?

By
February 27, 2015
Sanofi taps Bayer’s Brandicourt for CEO job
International

Sanofi taps Bayer’s Brandicourt for CEO job

By
February 20, 2015
The Food and Drug Administration (FDA) headquarters stand in
Features

Candidate to lead FDA has close ties to big pharma

By
February 19, 2015
cows
Leadership

Big Beef keeps getting bigger, thanks to growth drugs with unclear safety records

By
February 13, 2015
Inside Rite Aid Ahead of Earnings Reports
Retail

Rite Aid takes aim at CVS with a $2 billion purchase

By
February 11, 2015
Thiel, partner of Founders Fund, speaks during the panel discussion at the Milken Institute Global Conference in Beverly Hills, California
Leadership

Peter Thiel has never met a regulation he didn’t hate

By
February 11, 2015
161135392
Features

Biosimilars may one day save your life. But what are they?

By
February 6, 2015
IL: Corporations In Illinois
Finance

Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever

By
February 6, 2015

Most Popular